Comparing methods for estimating patient-specific treatment effects in individual patient data meta-analysis.

Bayesian analysis individual patient data meta-regression shrinkage variable selection

Journal

Statistics in medicine
ISSN: 1097-0258
Titre abrégé: Stat Med
Pays: England
ID NLM: 8215016

Informations de publication

Date de publication:
15 03 2021
Historique:
received: 02 04 2020
revised: 28 09 2020
accepted: 07 12 2020
pubmed: 29 12 2020
medline: 22 6 2021
entrez: 28 12 2020
Statut: ppublish

Résumé

Meta-analysis of individual patient data (IPD) is increasingly used to synthesize data from multiple trials. IPD meta-analysis offers several advantages over meta-analyzing aggregate data, including the capacity to individualize treatment recommendations. Trials usually collect information on many patient characteristics. Some of these covariates may strongly interact with treatment (and thus be associated with treatment effect modification) while others may have little effect. It is currently unclear whether a systematic approach to the selection of treatment-covariate interactions in an IPD meta-analysis can lead to better estimates of patient-specific treatment effects. We aimed to answer this question by comparing in simulations the standard approach to IPD meta-analysis (no variable selection, all treatment-covariate interactions included in the model) with six alternative methods: stepwise regression, and five regression methods that perform shrinkage on treatment-covariate interactions, that is, least absolute shrinkage and selection operator (LASSO), ridge, adaptive LASSO, Bayesian LASSO, and stochastic search variable selection. Exploring a range of scenarios, we found that shrinkage methods performed well for both continuous and dichotomous outcomes, for a variety of settings. In most scenarios, these methods gave lower mean squared error of the patient-specific treatment effect as compared with the standard approach and stepwise regression. We illustrate the application of these methods in two datasets from cardiology and psychiatry. We recommend that future IPD meta-analysis that aim to estimate patient-specific treatment effects using multiple effect modifiers should use shrinkage methods, whereas stepwise regression should be avoided.

Identifiants

pubmed: 33368415
doi: 10.1002/sim.8859
pmc: PMC7898845
doi:

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1553-1573

Subventions

Organisme : Medical Research Council
ID : MC_UU_12023/21
Pays : United Kingdom

Informations de copyright

© 2020 The Authors. Statistics in Medicine published by John Wiley & Sons, Ltd.

Références

J Affect Disord. 2019 May 1;250:419-424
pubmed: 30878654
Res Synth Methods. 2017 Sep;8(3):290-302
pubmed: 28378395
J Stat Softw. 2010;33(1):1-22
pubmed: 20808728
PLoS One. 2013 Apr 09;8(4):e60650
pubmed: 23585842
BMJ. 2017 Mar 3;356:j573
pubmed: 28258124
J Clin Epidemiol. 1999 Oct;52(10):935-42
pubmed: 10513756
Res Synth Methods. 2016 Sep;7(3):236-63
pubmed: 26754852
Stat Med. 2002 Jun 15;21(11):1559-73
pubmed: 12111920
Res Synth Methods. 2015 Dec;6(4):293-309
pubmed: 26287812
J Clin Epidemiol. 2015 Jan;68(1):52-60
pubmed: 25304503
Genet Sel Evol. 2004 May-Jun;36(3):261-79
pubmed: 15107266
Biom J. 2018 May;60(3):431-449
pubmed: 29292533
Stat Med. 1997 Feb 28;16(4):385-95
pubmed: 9044528
Biometrics. 2007 Sep;63(3):690-8
pubmed: 17403104
Stat Med. 2019 May 30;38(12):2228-2247
pubmed: 30672015
Stat Med. 2017 Feb 28;36(5):772-789
pubmed: 27910122
Stat Med. 2021 Mar 15;40(6):1553-1573
pubmed: 33368415
BMJ. 2009 Jun 29;338:b2393
pubmed: 19564179
BMC Med Res Methodol. 2014 Jun 19;14:79
pubmed: 24943877
Stat Med. 2017 Feb 28;36(5):855-875
pubmed: 27747915
Biometrics. 2003 Dec;59(4):762-9
pubmed: 14969453
BMJ. 2010 Feb 05;340:c221
pubmed: 20139215
Lancet. 2019 Jun 22;393(10190):2503-2510
pubmed: 31056295
Stat Med. 2015 Mar 15;34(6):984-98
pubmed: 25475839

Auteurs

Michael Seo (M)

Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Graduate School for Health Sciences, University of Bern, Bern, Switzerland.

Ian R White (IR)

MRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK.

Toshi A Furukawa (TA)

Departments of Health Promotion and Human Behavior and of Clinical Epidemiology, Kyoto University Graduate School of Medicine/School of Public Health, Kyoto, Japan.

Hissei Imai (H)

Departments of Health Promotion and Human Behavior and of Clinical Epidemiology, Kyoto University Graduate School of Medicine/School of Public Health, Kyoto, Japan.

Marco Valgimigli (M)

Department of Cardiology, Bern University Hospital, University of Bern, Bern, Switzerland.

Matthias Egger (M)

Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.

Marcel Zwahlen (M)

Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.

Orestis Efthimiou (O)

Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH